Arena Pharmaceuticals Reports on Launch of Belviq

barbara.lempert Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese — ...

Progenics Pharmaceuticals’ Data From a Phase 1 Study of PSMA ADC Presented

barbara.lempert Progenics Pharmaceuticals’ Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013 TARRYTOWN, N.Y., June 1, 2013 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, ...

Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786

barbara.lempert Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA Expedited Development Path will Allow ...

GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results

barbara.lempert -Conference Call Today at 8:00 a.m. ET, 1:00 p.m. BST- London, UK, 3 June 2013: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the ...

Aegerion Pharmaceuticals Receives Positive European CHMP Opinion for Lojuxta

barbara.lempert Aegerion Pharmaceuticals Receives Positive European CHMP Opinion for LOJUXTA(TM) (lomitapide) to Treat Homozygous Familial Hypercholesterolemia (HoFH) Company to Host ...

Idenix Pharmaceuticals Announces Initiation of Phase II All-Oral Combination Study of Samatasvir and Simeprevir

barbara.lempert Idenix Pharmaceuticals Announces Initiation of Phase II All-Oral Combination Study of Samatasvir (IDX719) and Simeprevir  (TMC435) for the Treatment of Hepatitis C ...

Satori Pharmaceuticals shuts down after failure of Alzheimer’s drug

Ryan McBride Satori Pharmaceuticals has closed its doors after running into safety problems in preclinical research of its lead program for Alzheimer's disease, FierceBiotech has ...

Synergy Pharmaceuticals Added to the MSCI Global Small Cap Indices

barbara.lempert NEW YORK, May 30, 2013 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, ...

Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel

barbara.lempert JERUSALEM May 30, 2013-Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that its wholly owned ...

Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results

barbara.lempert PRINCETON, N.J., May 28, 2013 /PRNewswire/ — Omthera Pharmaceuticals, Inc. (Nasdaq: OMTH), an emerging specialty pharmaceutical company, today announced its ...

Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca

barbara.lempert NEW YORK, May 28, 2013 /PRNewswire/ — Omthera Pharmaceuticals and AstraZeneca announced today that the companies entered into a merger agreement under which AstraZeneca ...

Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients

barbara.lempert MILFORD, Mass., May 23, 2013 /PRNewswire/ — Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of ...
Page 6 of 6« First...23456
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS